Literature DB >> 18928088

[Effect of xiaoyin recipe in treatment of psoriasis patients of blood-heat syndrome type and its impact on peripheral Th1/Th2 equilibrium].

Hong Zhang1, Xiao-guang Xu, Jun Gu.   

Abstract

OBJECTIVE: To explore the mechanism of Chinese medicinal therapy for cooling blood and removing stasis (CBRS) in treating psoriasis of blood-heat syndrome type by observing its clinical efficacy and impact on serum level of cytokines.
METHODS: Changes of psoriasis area and severity index (PASI) scores, scores of syndrome and serum levels of tumor necrosis factor alpha (TNF-alpha, Th1 cytokine) and interleukin-10 (IL-10, Th2 cytokine) in 32 psoriatic patients before and after treatment were observed.
RESULTS: The total effective rate after 4 weeks of treatment and 8 weeks of treatment was 65.63% (21/32 cases) and 75.00% (24/32 cases) respectively. Scores of PASI and syndrome all improved after treatment (P < 0.05). And comparison of TNF-alpha level before and after treatment also showed significant difference (P < 0.05) , whereas that of IL-10 was insignificant (P > 0.05). Moreover, a positive correlation was found between PASI scores and secreting level of TNF-alpha in patients with psoriasis (r = 0.3709, P < 0.05).
CONCLUSION: Chinese therapy for CBRS could play its effect in treating psoriasis by way of reducing TNF-alpha level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18928088

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Xiaoyin recipe ( ) for psoriasis induces a Th1/Th2 balance drift toward Th2 in peripheral blood mononuclear cells of experimental autoimmune thyroiditis rats.

Authors:  Xiao-Guang Xu; Hong Zhang; Xin-Ling Bi; Jun Gu; Yu-Ling Shi; Qiang Hou
Journal:  Chin J Integr Med       Date:  2012-02-05       Impact factor: 1.978

2.  Xiao-Yin-Fang Therapy Alleviates Psoriasis-like Skin Inflammation Through Suppressing γδT17 Cell Polarization.

Authors:  Xilin Zhang; Xiaorui Li; Youdong Chen; Bingjie Li; Chunyuan Guo; Peng Xu; Zengyang Yu; Yangfeng Ding; Yuling Shi; Jun Gu
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.